Antiphospholipid syndrome and cancer

Clinical Reviews in Allergy and Immunology

Volumn 32, Issue 2, 2007, Pages 184-187

  Reinstein, Eyal ^a,b   Shoenfeld, Yehuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antiphospholipid syndrome; Cancer; Thrombosis

Indexed keywords

ANTIPHOSPHOLIPID SYNDROME; CANCER; CANCER RESEARCH; DISEASE ASSOCIATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PATHOGENICITY; REVIEW; THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; HUMANS; NEOPLASMS; THROMBOSIS;

EID: 35348887163     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-007-0003-1     Document Type: Review

References (33)

1. Lip GY, Chin BS, Blann AD (2002) Cancer and the prothrombotic state. Lancet Oncol 3(1):27-34 (Jan)
2. Prandoni P, Falanga A, Piccioli A (2005) Cancer and venous thromboembolism. +Lancet Oncol 6(6):401-410 (Jun)
3. 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood 105:1540-1545
4. Lim W, Crowther MA, Eikelboom JW (2006) Management of antiphospholipid antibody syndrome: a systematic review. JAMA 295(9):1050-1057 (Mar 1)
5. de Groot PG, Derksen RH (2005) Pathophysiology of the antiphospholipid syndrome. J Thromb Haemost 3(8):1854-1860 (Aug)
6. Kozlowski CL, Johnson MJ, Gorst DW, Willey RF (1987) Lung cancer, immune thrombocytopenia and the lupus inhibitor. Postgrad Med J 63:793-795
7. Marous RM, Grayzel AL (1979) A lupus antibody syndrome associated with hypernephroma. Arthritis Rheum 22:1396-1398
8. Langer F, Eifrig B, Marx G, Stork A, Hegewisch-Becker S, Hossfeld DK (2002) Exacerbation of antiphospholipid antibody syndrome after treatment of localized cancer: a report of two cases. Ann Hematol 81(12):727-731 (Dec)
9. Park CJ, Cho HI, Kim SI (1991) A study on changes of coagulation inhibitors and fibrinolysis inhibitors in patients with liver cirrhosis and hepatoma. J Korean Med Sci 6(1):1-6 (Mar)
10. Soltesz P, Szekanecz Z, Vegh J, Lakos G, Toth L, Szakall S, Veres K, Szegedi G (2000) Catastrophic antiphospholipid syndrome in cancer. Haematologia (Bp) 30(4):303-311
11. Ruffatti A, Aversa S, Del Ross T, Tonetto S, Fiorentino M, Todesco S (1994) Antiphospholipid antibody syndrome associated with ovarian cancer. A new paraneoplastic syndrome? J Rheumatol 21(11):2162-2163 (Nov)
12. Miesbach W, Scharrer I, Asherson RA (2006) High titres of IgM-antiphospholipid antibodies are unrelated to pathogenicity in patients with non-Hodgkin's lymphoma. Clin Rheumatol 24 (May)
13. Donner M, Bekassy NA, Garwicz S, Holmberg L, Wiebe T (1992) Cerebral infarction in a girl who developed anticardiolipin syndrome after acute lymphoblastic leukemia. Pediatr Hematol Oncol 9(4):377-379 (Oct-Dec)
14. Mouas H, Lortholary O, Eclache V, Leroux G, Casassus P, Guillevin L, Raphael M (1994) Antiphospholipid syndrome during acute monocytic leukaemia. Eur J Haematol 53(1):59-60 (Jul)
15. Lossos IS, Bogomolski-Yahalom V, Matzner Y (1998) Anticardiolipin antibodies in acute myeloid leukemia: prevalence and clinical significance. Am J Hematol 57(2):139-143 (Feb)
16. Yahata N, Ohyashiki K, Iwama H, Katagiri T, Kodama S, Tauchi T, Yaguchi M, Toyama K (1997) Chronic myelomonocytic leukemia in a patient with antiphospholipid syndrome: first case report. Leuk Res 21(9):889-890 (Sep)
17. Duncombe AS, Dalton RG, Savidge GF (1987) Lupus-type coagulation inhibitor in hairy cell leukaemia and resolution with splenectomy. Br J Haematol 65(1):120-121 (Jan)
18. Asherson RA (2000) Antiphospholipid antibodies, malignancies and paraproteinemias. J Autoimmun 15(2):117-122 (Sep)
19. Asherson RA, Garcia-Carrasco M, Zeron PB, Ramos-Casals M. (2002) Antiphospholipid antibodies and malignancies. In: Asherson RA, Cervera J, Piette C, Shoenfeld Y (eds) The antiphospholipid syndrome II: autoimmune thrombosis. Elsevier, pp 317-327
20. Gomez-Puerta JA, Cervera R, Espinosa G, Aguilo S, Bucciarelli S, Ramos-Casals M, Ingelmo M, Asherson RA, Font J (2006) Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients. Semin Arthritis Rheum 35(5):322-332
21. Jude B, Goudemand J, Dolle I, Caron C, Watel A, Tiry C, Cosson A (1988) Lupus anticoagulant: a clinical and laboratory study of 100 cases. Clin Lab Haematol 10(1):41-51
22. Schved JF, Dupuy-Fons C, Biron C, Quere I, Janbon C (1994) A prospective epidemiological study on the occurrence of antiphospholipid antibody: the Montpellier Antiphospholipid (MAP) Study. Haemostasis 24(3):175-182 (May-Jun)
23. Finazzi G (1997) The Italian registry of antiphospholipid antibodies. Haematologica 82(1):101-105 (Jan-Feb)
24. Zuckerman E, Toubi E, Golan TD, Rosenvald-Zuckerman T, Sabo E, Shmuel Z, Yeshurun D (1995) Increased thromboembolic incidence in anti-cardiolipin- positive patients with malignancy. Br J Cancer 72 (2):447-451 (Aug)
25. Stasi R, Stipa E, Masi M, Oliva F, Sciarra A, Perrotti A, Zaccari G, Papa G (1993) Antiphospholipid antibodies: prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma. Thromb Haemost 70 (4):568-572 (Oct 18)
26. Pusterla S, Previtali S, Marziali S, Cortelazzo S, Rossi A, Barbui T, Galli M (2004) Antiphospholipid antibodies in lymphoma: prevalence and clinical significance. Hematol J 5(4):341-346
27. Miesbach W, Scharrer I, Asherson R (2006) Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies. Clin Rheumatol 25:1-5 (Jan)
28. Yoon KH, Wong A, Shakespeare T, Sivalingam P (2003) High prevalence of antiphospholipid antibodies in Asian cancer patients with thrombosis. Lupus 12(2):112-116
29. Miesbach W, Asherson RA, Cervera R, Shoenfeld Y, Gomez Puerta J, Bucciarelli S, Espinoza G, Font J and the members of the CAPS Registry Group (2006) The catastrophic antiphospholipid (Asherson's) syndrome and malignancies. Autoimmun Rev 6 (2):94-97
30. Endler G, Marsik C, Jilma B, Schickbauer T, Vormittag R, Wagner O, Mannhalter C, Rumpold H, Pabinger I (2006) Anti-cardiolipin antibodies and overall survival in a large cohort: preliminary report. Clin Chem 52(6):1040-1044 (Jun)
31. Cocca BA, Seal SN, D'Agnillo P, Mueller YM, Katsikis PD, Rauch J, Weigert M, Radic MZ (2001) Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells. Proc Natl Acad Sci USA 98(24):13826-13831 (Nov 20)
32. Buschmann C, Fischer C, Ochsenhirt V, Neukirch C, Lackner KJ, von Landenberg P (2005) Generation and characterization of three monoclonal IgM antiphospholipid antibodies recognizing different phospholipid antigens. Ann N Y Acad Sci 1051: 240-254 (Jun)
33. Langer F, Amirkhosravi A, Loges S, Meyer T, Eifrig B, Hossfeld DK, Fiedler W, Francis JL (2004) An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSF. Thromb Haemost 92(5): 1136-1146 (Nov)